Comparison of altered fractionation schedule with concurrent chemo-radiation for squamous cell carcinoma of head and neck
dc.contributor.author | K., Mathew Varghese | en_US |
dc.contributor.author | Narayanan, Geeta S. | en_US |
dc.contributor.author | Vishwanathan, Bhaskar | en_US |
dc.contributor.author | Karpurmath, Shashidhar V. | en_US |
dc.contributor.author | Narayanan, Soumya | en_US |
dc.date.accessioned | 2020-11-18T10:02:14Z | |
dc.date.available | 2020-11-18T10:02:14Z | |
dc.date.issued | 2020-08 | |
dc.description.abstract | Background: Aim of the study was to compare the response of altered fractionation schedule with concurrent chemo-radiation in patients with primary and the nodal disease.Methods: Total of 40 patients (20 in each arm) with stage 1- 4 squamous cell carcinoma of the head and neck with a performance status of 0-2 (ECOG) were included in the study. Arm A was altered fractionation schedule where in patients received 6 fractions per week to a total dose of 6600 cGy in 33 fractions. In Arm B, patients received conventional radiotherapy with concurrent chemotherapy three weekly Inj. of cisplatin (100 mg/m2). Patients were evaluated for acute toxicity every week using the Acute Radiation Morbidity Scoring Criteria. The response was assessed after 6 weeks and 12 weeks post treatment using the RECIST criteria. Data was statistically analyzed.Results: Seventeen patients in Arm A and 18 patients in Arm B completed the treatment. At the end of three months, In Arm A, 7 patients had complete response and in Arm B, 9 patients had complete response of the primary (p>0.05). When the complete nodal response was compared in both the arms, there was no difference (2 vs 4 in Arm A vs Arm B resp.). But there were more partial nodal responders in Arm B (p = 0.016). The acute toxicities were comparable in both the arms.Conclusions: Altered fraction radiotherapy can be used in early lesions with minimal nodal burden but with locally advanced disease or large nodal burden addition of chemotherapy should not be avoided. | en_US |
dc.identifier.affiliations | Department of Radiation Oncology, Amala Institute of Medical Sciences, Thrissur-680 555, Kerala, India | en_US |
dc.identifier.affiliations | Department of Radiation Oncology, Vydehi Institute of Medical Sciences, Bengaluru, Karnataka, India | en_US |
dc.identifier.affiliations | Department of Medical Oncology, Vydehi Institute of Medical Sciences, Bengaluru, Karnataka, India | en_US |
dc.identifier.affiliations | Department of Medical Physics, Vydehi Institute of Medical Sciences, Bengaluru, Karnataka, India | en_US |
dc.identifier.citation | K. Mathew Varghese, Narayanan Geeta S., Vishwanathan Bhaskar, Karpurmath Shashidhar V., Narayanan Soumya. Comparison of altered fractionation schedule with concurrent chemo-radiation for squamous cell carcinoma of head and neck. International Journal of Research in Medical Sciences. 2020 Aug; 8(8): 2834-2838 | en_US |
dc.identifier.issn | 2320-6071 | |
dc.identifier.issn | 2320-6012 | |
dc.identifier.place | India | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/212515 | |
dc.language | en | en_US |
dc.publisher | Medip Academy | en_US |
dc.relation.issuenumber | 8 | en_US |
dc.relation.volume | 8 | en_US |
dc.source.uri | https://dx.doi.org/10.18203/2320-6012.ijrms20203095 | en_US |
dc.subject | Acute toxicity | en_US |
dc.subject | Altered fractionation | en_US |
dc.subject | Concurrent chemo-radiation | en_US |
dc.subject | Radiotherapy | en_US |
dc.subject | Squamous cell carcinoma of head and neck | en_US |
dc.title | Comparison of altered fractionation schedule with concurrent chemo-radiation for squamous cell carcinoma of head and neck | en_US |
dc.type | Journal Article | en_US |
Files
Original bundle
1 - 1 of 1